Precision Insights
for Every Patient You Treat
High-quality genomic testing, clinical integration, and sponsored programs that enable evidence-based care across Latin America.
Our Genomic Testing Portfolio
We offer a comprehensive suite of next-generation sequencing (NGS) and biomarker tests designed to guide treatment selection across solid tumors.
Our core assays include:
Tissue Complete
500-gene panel
Comprehensive tumor profiling for actionable alterations.
Liquid Complete
500-gene ctDNA panel
Non-invasive profiling for monitoring and identifying treatment options.
Certified Precision
ISO 9001:2015–certified labs with external validation from EMQN, GenQA, NordiQC, and CAP—supporting reliable, clinically actionable results for every patient. View Our Quality Policy —>
Order, Track, and Review in One Place
PLUTON is your centralized platform for managing Biomakers tests across the full clinical workflow.
With PLUTON, physicians can:
Sponsored Testing: Program overview for eligible patients
Access to Pharma-Sponsored Genomic Testing
Biomakers partners with leading biopharma companies to provide no-cost genomic testing for eligible patients across Latin America.
These programs support
Matching patients to targeted therapies and clinical trials
Identification of actionable mutations
For Institutions Not Yet Enrolled
Your center can join our sponsored testing network to provide expanded access to precision oncology tools, enhance clinical research participation, and improve treatment options for your patient population.
Infinity: Secure Data Integration for Oncology Institutions
Infinity enables oncology institutions in Latin America to securely share real-world clinical and molecular data with global research, without disrupting workflows.
How Infinity Works
Infinity operates as an integration layer within your institution.
Clinical, pathology, and molecular data remain under institutional control while being securely ingested, standardized, and de-identified to support approved research and innovation programs.
No system replacement. No operational burden.
How it Works
Secure Integration
Runs alongside existing clinical systems and workflows
Governed Data Flow
De-identified, consented, and auditable data ingestion
Research-Ready Outputs
Structured datasets available only through approved programs
Why Institutions Partner with Biomakers
Collaborative Research & Publications
Participate in global research initiatives and co-authored publications.
Access to Global R&D Programs
Enable participation in biopharma and diagnostic development programs.
Data-Enabled Revenue Streams
Generate value from existing data assets through transparent, approved use.
Zero Additional Infrastructure
No new systems, hardware, or operational complexity required.
Trust & Stewardship
Fully informed patient consent
De-identified clinical and molecular data
Local IRB / Ethics Committee approval
Transparent data-use agreements defining access and application
